1673546-62-7: Trifluoro Acetyl Amino Linagliptin

Trifluoro Acetyl Amino Linagliptin (CAS No: 1673546-62-7) Or (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide, Linagliptin is a potent inhibitor of dipeptidyl peptidase 4 ,it is a medication used to treat diabetes mellitus type 2.

Additional information on CAS 1673546-62-7

Catalogue No.

VE008477

CAS No.

1673546-62-7

Molecular Formula

C27H27F3N8O3

Molecular Weight

568.56 g/mol

Parent drug

Linagliptin

IUPAC Name

(R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2, 6-dioxo-2, 3, 6, 7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2, 2, 2-trifluoroacetamide

Synonyms

N/A

References

Sci-Hub, Effect of linagliptin monotherapy on glycaemic control and markers of v-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial, 10.1111/j.1463-1326.2010.01350.x. (2011). Retrieved December 26, 2021, from Sci-hub.ee website: https://sci-hub.ee/https://doi.org/10.1111/j.1463-1326.2010.01350.x

Status

In-stock